Premium
Synthesis, biological activities, and docking study of novel chalcone‐pleuromutilin derivatives
Author(s) -
Xie Chuan,
Zhang Siyu,
Zhang Wei,
Wu Chunxia,
Yong Can,
Sun Yuhao,
Zeng Zhengxing,
Zhang Qian,
Huang Zixin,
Chen Tian,
Zhang Yuanyuan
Publication year - 2020
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/cbdd.13692
Subject(s) - chalcone , docking (animal) , moiety , mode of action , chemistry , staphylococcus aureus , stereochemistry , combinatorial chemistry , antibacterial activity , biochemistry , antibiotics , microbiology and biotechnology , biology , bacteria , medicine , nursing , genetics
The issue of antibiotic resistance is becoming progressively serious these days, and the feasible solution to address it is to develop and discover novel antibiotics. The diterpene natural pleuromutilin is a prominent candidate for its special mode of action by inhibiting protein synthesis. In this study, a series of novel pleuromutilin derivatives with chalcone moiety was designed and synthesized, and their antibacterial activities were assessed in vitro. As suggested from the results, most of compounds exhibited potent activities against two methicillin‐resistant Staphylococcus aureus (MRSA) ATCC 33591 and 43300. The further modification of the chalcone structure, aza‐cyclic derivatives were afforded and then assessed, and potent activities against the tested strains were reported. The preliminary docking studies were conducted to explore the interactions between target molecules and binding site.